Provir oral inhibitor of chloride ion secretion data

SHMN announced Phase II results in 75 patients, with 89 percent of those treated with 1 or 2 g/day experiencing rapid

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE